Aptamer-Based Multiplexed Proteomic Technology for Biomarker Discovery
Open accessThe DOI matches its Crossref record; 44 of the 46 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The interrogation of proteomes ("proteomics") in a highly multiplexed and efficient manner remains a coveted and challenging goal in biology and medicine. METHODOLOGY/PRINCIPAL FINDINGS: We present a new aptamer-based proteomic technology for biomarker discovery capable of simultaneously measuring thousands of proteins from small sample volumes (15 µL of serum or plasma). Our current assay measures 813 proteins with low limits of detection (1 pM median), 7 logs of overall dynamic range (~100 fM-1 µM), and 5% median coefficient of variation. This technology is enabled by a new generation of aptamers that contain chemically modified nucleotides, which greatly expand the physicochemical diversity of the large randomized nucleic acid libraries from which the aptamers are selected. Proteins in complex matrices such as plasma are measured with a process that transforms a signature of protein concentrations into a corresponding signature of DNA aptamer concentrations, which is quantified on a DNA microarray. Our assay takes advantage of the dual nature of aptamers as both folded protein-binding entities with defined shapes and unique nucleotide sequences recognizable by specific hybridization probes. To demonstrate the utility of our proteomics biomarker discovery technology, we applied it to a clinical study of chronic kidney disease (CKD). We identified two well known CKD biomarkers as well as an additional 58 potential CKD biomarkers. These results demonstrate the potential utility of our technology to rapidly discover unique protein signatures characteristic of various disease states. CONCLUSIONS/SIGNIFICANCE: We describe a versatile and powerful tool that allows large-scale comparison of proteome profiles among discrete populations. This unbiased and highly multiplexed search engine will enable the discovery of novel biomarkers in a manner that is unencumbered by our incomplete knowledge of biology, thereby helping to advance the next generation of evidence-based medicine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures













Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Major developments in mass spectrometry-based, antibody-based and aptamer-based proteomics over the past decade have enabled the robust quantification of thousands of proteins in single samples87–90.”
From Measuring biological age using omics data (2022) · cites this paper as [89]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The assay uses DNA-based slow off-rate modified aptamers (SOMAmerTM reagents) to quantify the relative abundance of approximately 7000 proteins with high specificity and limits of detection largely comparable to antibody-based assays.”
From Cross-ancestry comparison of aptamer and antibody protein measures (2026) · cites this paper as [53]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Proteomic technologies, including mass spectrometry–based proteomics, aptamer-based arrays (SomaLogic), and proximity extension assay technology (Olink), are now available for the large-scale quantification and validation of thousands of proteins in human biological fluids or tissues (122–127).”
From Connecting aging biology and inflammation in the omics era (2022) · cites this paper as [127]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RNA-Mediated Metal-Metal Bond Formation in the Synthesis of Hexagonal Palladium Nanoparticles
Gugliotti, L. A., Feldheim, D. L., & Eaton, B. E. (2004) · Science · doi:10.1126/science.1095678 · Cited by 197 · cited 2×
“This innovation was used to select catalysts, including the first RNA-catalyzed carbon-carbon bond formation [16,23].”
MethodSelf-citationRetractedLevey, A. S., Bosch, J. P., Lewis, J. B., Greene, T., Rogers, N., Roth, D., & for the Modification of Diet in Renal Disease Study Group* (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-6-199903160-00002 · Cited by 15,079
Tuerk, C., & Gold, L. (1990) · Science · doi:10.1126/science.2200121 · Cited by 10,405 · cited 4×
“Based on the collective knowledge of the aptamer field that has developed since its inception [13,14], we hypothesized that aptamers could make exceptional reagents for high-content proteomics.”
BackgroundInfluentialSelf-citationIn vitro selection of RNA molecules that bind specific ligands
Ellington, A. D., & Szostak, J. W. (1990) · Nature · doi:10.1038/346818a0 · Cited by 9,812 · cited 4×
“Based on the collective knowledge of the aptamer field that has developed since its inception [13,14], we hypothesized that aptamers could make exceptional reagents for high-content proteomics.”
BackgroundInfluentialKeller, A., Nesvizhskii, A. I., Kolker, E., & Aebersold, R. (2002) · Analytical Chemistry · doi:10.1021/ac025747h · Cited by 4,830 · cited 2×
“0% probability as specified by the Peptide Prophet algorithm [45].”
MethodA Statistical Model for Identifying Proteins by Tandem Mass Spectrometry
Nesvizhskii, A. I., Keller, A., Kolker, E., & Aebersold, R. (2003) · Analytical Chemistry · doi:10.1021/ac0341261 · Cited by 4,809 · cited 3×
“Protein probabilities were assigned by the Protein Prophet algorithm [44].”
MethodAssessing Kidney Function — Measured and Estimated Glomerular Filtration Rate
Stevens, L. A., Coresh, J., Greene, T., & Levey, A. S. (2006) · New England Journal of Medicine · doi:10.1056/nejmra054415 · Cited by 2,952 · cited 2×
“Eleven subjects had early-stage CKD based on estimated GFR (Table 3) (eGFR, defined as stages 1–2, median creatinine clearance 70 ml/min/m, range 62–97 ml/min/m) and 31 had late-stage CKD (stages 3–5, median creatinine clearance 25 ml/min/m, range 7–49 ml/min/m) [33].”
BackgroundPegaptanib for neovascular age-related macular degeneration
Gragoudas, E. S., Adamis, A. P., Cunningham, E. T., Feinsod, M., & Guyer, D. R. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa042760 · Cited by 2,337 · cited 1×
“Aptamers are a class of nucleic acid-based molecules discovered twenty years ago [13,14] and have since been employed in diverse applications including therapeutics [15], catalysis [16], and now proteomics.”
BackgroundHopfield, J. J. (1974) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.71.10.4135 · Cited by 1,594 · cited 2×
“Inspired by classic kinetic theory of specific binding in complex mixtures [25,26], we employed kinetic manipulations to help overcome the problem of non-specific SOMAmer-protein binding.”
MethodLevey, A. S., Atkins, R., Coresh, J., Cohen, E. P., Collins, A. J., Eckardt, K.-U., Nahas, M. E., Jaber, B. L., Jadoul, M., Levin, A., et al. (2007) · Kidney International · doi:10.1038/sj.ki.5002343 · Cited by 1,516 · cited 4×
“CKD biomarkers could also be useful for monitoring disease progression and guiding treatment [28–31].”
BackgroundInfluential
Cited by
Items 201–300 of 1,009
Wang, Y. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.03.008 · Cited by 114
Aptamers: current challenges and future prospects
Rozenblum, G. T., Lopez, V. G., Vitullo, A. D., & Radrizzani, M. (2015) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2016.1126244 · Cited by 114
Evolution of sequence-defined highly functionalized nucleic acid polymers
Chen, Z., Lichtor, P. A., Berliner, A. P., Chen, J. C., & Liu, D. R. (2018) · Nature Chemistry · doi:10.1038/s41557-018-0008-9 · Cited by 110
Rutledge, J., Lehallier, B., Zarifkar, P., Losada, P. M., Shahid, M., Western, D., Gorijala, P., Ryman, S. G., Yutsis, M. V., Deutsch, G. K., et al. (2024) · Acta Neuropathologica · doi:10.1007/s00401-024-02706-0 · Cited by 125
Screening and Identifying a Novel ssDNA Aptamer against Alpha-fetoprotein Using CE-SELEX
Dong, L., Tan, Q., Ye, W., Liu, D., Chen, H., Hu, H., Wen, D., Liu, Y., Cao, Y., Kang, J., et al. (2015) · Scientific Reports · doi:10.1038/srep15552 · Cited by 107
Probing the Limits of Aptamer Affinity with a Microfluidic SELEX Platform
Ahmad, K. M., Oh, S. S., Kim, S. W., McClellen, F. M., Xiao, Y., & Soh, H. T. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027051 · Cited by 123
Tin, A., Yu, B., Ma, J., Masushita, K., Daya, N., Hoogeveen, R. C., Ballantyne, C. M., Couper, D., Rebholz, C. M., Grams, M. E., et al. (2019) · The Journal of Applied Laboratory Medicine · doi:10.1373/jalm.2018.027086 · Cited by 106
Tarca, A. L., Pataki, B., Romero, R. J., Sirota, M., Guan, Y., Kutum, R., Gomez‐Lopez, N., Done, B., Bhatti, G., Yu, T. V., et al. (2021) · Cell Reports Medicine · doi:10.1016/j.xcrm.2021.100323 · Cited by 121
Analytical techniques for multiplex analysis of protein biomarkers
van Gool, A. J., Corrales, F. J., Čolović, M. B., Krstic, D. Z., Oliver‐Martos, B., Martínez-Cáceres, E. M., Jakaša, I., Gajski, G., Brun, V., Kyriacou, K. C., et al. (2020) · Expert Review of Proteomics · doi:10.1080/14789450.2020.1763174 · Cited by 120
Revealing the role of the human blood plasma proteome in obesity using genetic drivers
Zaghlool, S. B., Sharma, S., Molnar, M., Matías-García, P. R., Elhadad, M. A., Waldenberger, M., Peters, A., Rathmann, W., Graumann, J., Gieger, C., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21542-4 · Cited by 102
Snider, J. M., You, J. K., Wang, X., Snider, A. J., Hallmark, B., Zec, M. M., Seeds, M. C., Sergeant, S., Johnstone, L. M., Wang, Q., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci149236 · Cited by 111
Engineering synthetic RNA devices for cell control
Dykstra, P. B., Kaplan, M., & Smolke, C. D. (2022) · Nature Reviews Genetics · doi:10.1038/s41576-021-00436-7 · Cited by 137
Musumeci, D., & Montesarchio, D. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.07.011 · Cited by 103
From selection hits to clinical leads: progress in aptamer discovery
Maier, K. E., & Levy, M. (2016) · Molecular Therapy — Methods & Clinical Development · doi:10.1038/mtm.2016.14 · Cited by 108
A proteomic clock of human pregnancy
Aghaeepour, N., Lehallier, B., Baca, Q. J., Ganio, E. A., Wong, R. J., Ghaemi, M. S., Culos, A., El-Sayed, Y. Y., Blumenfeld, Y. J., Druzin, M. L., et al. (2017) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2017.12.208 · Cited by 106
Modified Nucleic Acids: Expanding the Capabilities of Functional Oligonucleotides
Ochoa, S., & Milam, V. T. (2020) · Molecules · doi:10.3390/molecules25204659 · Cited by 113
ProteinSeq: High-Performance Proteomic Analyses by Proximity Ligation and Next Generation Sequencing
Darmanis, S., Nong, R. Y., Vänelid, J., Siegbahn, A., Ericsson, O., Fredriksson, S., Bäcklin, C., Gut, M., Heath, S., Gut, I. G., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025583 · Cited by 102
Periostin-binding DNA Aptamer Inhibits Breast Cancer Growth and Metastasis
Lee, Y. J., Kim, I. S., Park, S.-A., Kim, Y., Lee, J. E., Noh, D.-Y., Kim, K.-T., Ryu, S. H., & Suh, P.-G. (2013) · Molecular Therapy · doi:10.1038/mt.2013.30 · Cited by 102
Efficacy of Base-Modification on Target Binding of Small Molecule DNA Aptamers
Imaizumi, Y., Kasahara, Y., Fujita, H., Kitadume, S., Ozaki, H., Endoh, T., Kuwahara, M., & Sugimoto, N. (2013) · Journal of the American Chemical Society · doi:10.1021/ja4012222 · Cited by 114
Koch, C., Reilly-O’Donnell, B., Gutierrez, R., Lucarelli, C., Ng, F. S., Gorelik, J., Ivanov, A. P., & Edel, J. B. (2023) · Nature Nanotechnology · doi:10.1038/s41565-023-01479-z · Cited by 119
Crystal Structure of Interleukin-6 in Complex with a Modified Nucleic Acid Ligand
Gelinas, A. D., Davies, D. R., Edwards, T. E., Rohloff, J. C., Carter, J. D., Zhang, C., Gupta, S., Ishikawa, Y., Hirota, M., Nakaishi, Y., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.532697 · Cited by 109
Self-citationArtificially Expanded Genetic Information Systems for New Aptamer Technologies
Biondi, E., & Benner, S. A. (2018) · Biomedicines · doi:10.3390/biomedicines6020053 · Cited by 110
Kivimäki, M., Walker, K. A., Pentti, J., Nyberg, S. T., Mars, N., Vahtera, J., Suominen, S. B., Lallukka, T., Rahkonen, O., Pietiläinen, O., et al. (2021) · BMJ · doi:10.1136/bmj.n1804 · Cited by 99
Penn‐Nicholson, A., Hraha, T. H., Thompson, E. G., Sterling, D., Mbandi, S. K., Wall, K. M., Fisher, M., Suliman, S., Shankar, S., Hanekom, W. A., et al. (2019) · PLoS Medicine · doi:10.1371/journal.pmed.1002781 · Cited by 107
Self-citationSebastiani, P., Federico, A., Morris, M., Gurinovich, A., Tanaka, T., Chandler, K. B., Andersen, S. L., Denis, G., Costello, C. E., Ferrucci, L., et al. (2021) · Aging Cell · doi:10.1111/acel.13290 · Cited by 103
Williams, S. A., Ostroff, R., Hinterberg, M. A., Coresh, J., Ballantyne, C. M., Matsushita, K., Mueller, C. E., Walter, J., Jonasson, C., Holman, R. R., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abj9625 · Cited by 97
Self-citationPlasma proteomic profile of age, health span, and all‐cause mortality in older adults
Sathyan, S., Ayers, E., Gao, T., Weiss, E. F., Milman, S., Verghese, J., & Barzilai, N. (2020) · Aging Cell · doi:10.1111/acel.13250 · Cited by 96
Groote, M. A. D., Sterling, D. G., Hraha, T. H., Russell, T. M., Green, L. S., Wall, K. M., Kräemer, S., Ostroff, R. M., Janjić, N., & Ochsner, U. A. (2017) · Journal of Clinical Microbiology · doi:10.1128/jcm.00467-17 · Cited by 105
Self-citationFluorescence Sensing Using DNA Aptamers in Cancer Research and Clinical Diagnostics
Musumeci, D., Platella, C., Riccardi, C., Moccia, F., & Montesarchio, D. (2017) · Cancers · doi:10.3390/cancers9120174 · Cited by 103
Röthlisberger, P., Gasse, C., & Hollenstein, M. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18112430 · Cited by 100
Directed Evolution of Aptamer Discovery Technologies
Wu, D., Gordon, C. K. L., Shin, J. H., Eisenstein, M. S., & Soh, H. T. (2022) · Accounts of Chemical Research · doi:10.1021/acs.accounts.1c00724 · Cited by 98
Proteostasis and lysosomal repair deficits in transdifferentiated neurons of Alzheimer’s disease
Chou, C.-C., Vest, R., Prado, M. A., Wilson-Grady, J., Paulo, J. A., Shibuya, Y., Moran-Losada, P., Lee, T.-T., Luo, J., Gygi, S. P., et al. (2025) · Nature Cell Biology · doi:10.1038/s41556-025-01623-y · Cited by 94
Identification and characterization of nucleobase-modified aptamers by click-SELEX
Pfeiffer, F., Tölle, F., Rosenthal, M., Brändle, G. M., Ewers, J., & Mayer, G. (2018) · Nature Protocols · doi:10.1038/nprot.2018.023 · Cited by 102
Protein Signature of Lung Cancer Tissues
Mehan, M. R., Ayers, D., Thirstrup, D., Xiong, W., Ostroff, R. M., Brody, E. N., Walker, J. J., Gold, L., Jarvis, T. C., Janjic, N., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035157 · Cited by 92
Self-citationChan, M. Y., Motakis, E., Tan, S. H., Pickering, J. W., Troughton, R. W., Pemberton, C., Ho, H., Prabath, J. F., Drum, C. L., Ling, L. H., et al. (2020) · Circulation · doi:10.1161/circulationaha.119.045158 · Cited by 103
Katz, D. H., Tahir, U. A., Bick, A. G., Pampana, A., Ngo, D., Benson, M. D., Yu, Z., Robbins, J. M., Chen, Z.-Z., Cruz, D. E., et al. (2022) · Circulation · doi:10.1161/circulationaha.121.055117 · Cited by 92
Self-citationGDF 15 is a heart‐derived hormone that regulates body growth
Wang, T., Liu, J., McDonald, C., Lupino, K., Zhai, X., Wilkins, B. J., Hakonarson, H., & Pei, L. (2017) · EMBO Molecular Medicine · doi:10.15252/emmm.201707604 · Cited by 90
SOMAscan Proteomics Identifies Serum Biomarkers Associated With Liver Fibrosis in Patients With NASH
Luo, Y., Wadhawan, S., Greenfield, A., Decato, B. E., Oseini, A. M., Collen, R., Shevell, D. E., Thompson, J., Jarai, G., Charles, E. D., et al. (2021) · Hepatology Communications · doi:10.1002/hep4.1670 · Cited by 87
“762 specificity.(11) SOMAscan has been used to identify diagnostic signatures of several other diseases.”
MethodPlasma proteomics identifies a ‘chemokine storm’ in idiopathic multicentric Castleman disease
Pierson, S. K., Stonestrom, A. J., Shilling, D., Ruth, J., Nabel, C. S., Singh, A., Ren, Y., Stone, K., Li, H., van Rhee, F., et al. (2018) · American Journal of Hematology · doi:10.1002/ajh.25123 · Cited by 90
Maksymowych, W. P. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00305 · Cited by 105
“These consist of a short singlestranded DNA sequence incorporating a series of modifications that give the SOMAmer “protein-like” appendages that allow the SOMAmer to tightly bind its target protein (55).”
BackgroundDayon, L., Cominetti, O., & Affolter, M. (2022) · Expert Review of Proteomics · doi:10.1080/14789450.2022.2070477 · Cited by 106
Discovery of sparse, reliable omic biomarkers with Stabl
Hedou, J. J., Marić, I., Bellan, G., Einhaus, J. F., Gaudilliere, D. K., Ladant, F.-X., Verdonk, F., Stelzer, I. A., Feyaerts, D., Tsai, A. S., et al. (2024) · Nature Biotechnology · doi:10.1038/s41587-023-02033-x · Cited by 107
Aptamer Selection by High-Throughput Sequencing and Informatic Analysis
Hoon, S. S., Zhou, B., Janda, K. D., Brenner, S., & Scolnick, J. A. (2011) · BioTechniques · doi:10.2144/000113786 · Cited by 89
Zhang, L., Yang, Z., Trinh, T. L., Teng, I., Wang, S., Bradley, K. M., Hoshika, S., Wu, Q., Cansız, S., Rowold, D. J., et al. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201605058 · Cited by 92
D’Alessandro, E., Becker, C., Bergmeier, W., Bode, C., Bourne, J. H., Brown, H. C., Buller, H. R., ten Cate‐Hoek, A. J., ten Cate, V., van Cauteren, Y. J. M., et al. (2020) · Thrombosis and Haemostasis · doi:10.1055/s-0040-1708035 · Cited by 102
Corey, K. E., Pitts, R., Lai, M., Loureiro, J., Masia, R., Osganian, S. A., Gustafson, J. L., Hutter, M. M., Gee, D. W., Meireles, O. R., et al. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2021.09.026 · Cited by 88
Romero, R. J., Erez, O., Maymon, E., Chaemsaithong, P., Xu, Z., Pacora, P., Chaiworapongsa, T., Done, B., Hassan, S. S., & Tarca, A. L. (2017) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2017.02.037 · Cited by 100
Profiling of the plasma proteome across different stages of human heart failure
Egerstedt, A., Berntsson, J., Smith, M. L., Gidlöf, O., Nilsson, R., Benson, M. D., Wells, Q. S., Celik, S., Lejonberg, C., Farrell, L. A., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-13306-y · Cited by 99
SELEX Modifications and Bioanalytical Techniques for Aptamer–Target Binding Characterization
Tan, S. Y., Acquah, C., Sidhu, A. S., Ongkudon, C. M., Yon, L. S., & Danquah, M. K. (2016) · Critical Reviews in Analytical Chemistry · doi:10.1080/10408347.2016.1157014 · Cited by 92
Human plasma proteomic profiles indicative of cardiorespiratory fitness
Robbins, J., Peterson, B. D., Schranner, D., Tahir, U. A., Rienmüller, T. M., Deng, S., Keyes, M. J., Katz, D. H., Beltran, P. M. J., Barber, J. L., et al. (2021) · Nature Metabolism · doi:10.1038/s42255-021-00400-z · Cited by 96
Identification of cis-regulatory variation influencing protein abundance levels in human plasma
Lourdusamy, A., Newhouse, S., Lunnon, K., Proitsi, P., Powell, J., Hodges, A., Nelson, S. K., Stewart, A., Williams, S., Kloszewska, I., et al. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds186 · Cited by 87
Self-citationAdvances in Aptamer-Based Biomarker Discovery
Huang, J., Chen, X., Fu, X., Li, Z., Huang, Y., & Liang, C. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.659760 · Cited by 95
Proteomic changes upon treatment with semaglutide in individuals with obesity
Maretty, L., Gill, D., Simonsen, L., Soh, K., Zagkos, L., Galanakis, M., Sibbesen, J., Iglesias, M. T., Secher, A., Valkenborg, D., et al. (2025) · Nature Medicine · doi:10.1038/s41591-024-03355-2 · Cited by 86
“The SomaScan® aptamer-based proteomic platform was the first high-throughput platform used in large-scale studies 8 capable of simultaneously measuring the relative abundance of thousands of proteins from small sample volumes.”
Plubell, D. L., Käll, L., Webb-Robertson, B.-J., Bramer, L. M., Ives, A., Kelleher, N. L., Smith, L. M., Montine, T. J., Wu, C. C., & MacCoss, M. J. (2022) · Journal of Proteome Research · doi:10.1021/acs.jproteome.1c00894 · Cited by 85
Wang, Y., Liu, E., Lam, C. H., & Perrin, D. M. (2018) · Chemical Science · doi:10.1039/c7sc04491g · Cited by 90
Protein quantitative trait locus study in obesity during weight-loss identifies a leptin regulator
Carayol, J., Chabert, C., Di Cara, A., Armenise, C., Lefebvre, G., Langin, D., Viguerie, N., Metairon, S., Saris, W. H. M., Astrup, A., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-02182-z · Cited by 84
Therapeutic Potential of Aptamer–Protein Interactions
Shraim, A. S., Majeed, B. A. A., Al-Binni, M. A., & Hunaiti, A. A. (2022) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.2c00156 · Cited by 97
Sung, Y. J., Yang, C., Norton, J., Johnson, M., Fagan, A., Bateman, R. J., Perrin, R. J., Morris, J. C., Farlow, M. R., Chhatwal, J. P., et al. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.abq5923 · Cited by 84
Zaghlool, S. B., Kühnel, B., Elhadad, M. A., Kader, S. A., Halama, A., Thareja, G., Engelke, R., Sarwath, H., Al‐Dous, E., Mohamoud, Y. A., et al. (2020) · Nature Communications · doi:10.1038/s41467-019-13831-w · Cited by 83
Synthetic biology toolkits and applications in Saccharomyces cerevisiae
Chen, B., Lee, H. L., Heng, Y. C., Chua, N., Teo, W. S., Choi, W. J., Leong, S. S. J., Foo, J. L., & Chang, M. W. (2018) · Biotechnology Advances · doi:10.1016/j.biotechadv.2018.07.005 · Cited by 89
Proteomic and Metabolomic Correlates of Healthy Dietary Patterns: The Framingham Heart Study
Walker, M. E., Song, R. J., Xu, X., Gerszten, R. E., Ngo, D., Clish, C. B., Corlin, L., Ma, J., Xanthakis, V., Jacques, P. F., et al. (2020) · Nutrients · doi:10.3390/nu12051476 · Cited by 90
The application of Aptamer in biomarker discovery
Li, Y., Tam, W. W. L., Yu, Y., Zhuo, Z., Xue, Z., Tsang, C., Qiao, X., Wang, W., Wang, W., Li, Y., et al. (2023) · Biomarker Research · doi:10.1186/s40364-023-00510-8 · Cited by 87
Cancer protein biomarker discovery based on nucleic acid aptamers
Xiong, H., Yan, J., Cai, S., He, Q., Peng, D., Liu, Z., & Liu, Y. (2019) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2019.03.165 · Cited by 80
Metabolic and proteomic signatures of type 2 diabetes subtypes in an Arab population
Zaghlool, S. B., Halama, A., Stephan, N., Gudmundsdottir, V., Gudnason, V., Jennings, L. L., Thangam, M., Ahlqvist, E., Malik, R. A., Albagha, O. M. E., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-34754-z · Cited by 79
Validation of a blood protein signature for non-small cell lung cancer
Mehan, M. R., Williams, S. A., Siegfried, J. M., Bigbee, W. L., Weissfeld, J. L., Wilson, D. O., Pass, H. I., Rom, W. N., Muley, T., Meister, M. A., et al. (2014) · Clinical Proteomics · doi:10.1186/1559-0275-11-32 · Cited by 86
Self-citationChu, S. H., Huang, M., Kelly, R. S., Benedetti, E., Siddiqui, J., Zeleznik, O. A., Pereira, A., Herrington, D. M., Wheelock, C. E., Krumsiek, J., et al. (2019) · Metabolites · doi:10.3390/metabo9060117 · Cited by 89
Baird, G. S. (2010) · American Journal of Clinical Pathology · doi:10.1309/ajcpfu4cg2wgjjks · Cited by 100
Blundell, E. L. C. J., Vogel, R., & Platt, M. (2016) · Langmuir · doi:10.1021/acs.langmuir.5b03024 · Cited by 80
Evolution of Complex Target SELEX to Identify Aptamers against Mammalian Cell-Surface Antigens
Mallikaratchy, P. R. (2017) · Molecules · doi:10.3390/molecules22020215 · Cited by 88
Aptamers and antibodies in optical biosensing
Mpofu, K. T., Chauke, S. H., Thwala, L. N., & Mthunzi-Kufa, P. T. (2025) · Discover Chemistry. · doi:10.1007/s44371-025-00094-2 · Cited by 98
Immunotherapy of CD30-expressing lymphoma using a highly stable ssDNA aptamer
Parekh, P. A., Kamble, S., Zhao, N., Zeng, Z., Portier, B. P., & Zu, Y. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.07.099 · Cited by 80
Li, J., Xu, M., Huang, H., Zhou, J., Abdel-Halim, E. S., Zhang, J., & Zhu, J. (2011) · Talanta · doi:10.1016/j.talanta.2011.07.055 · Cited by 84
Diagnostic and prognostic biomarkers for malignant mesothelioma: an update
Chen, Z., Gaudino, G., Pass, H. I., Carbone, M., & Yang, H. (2017) · Translational Lung Cancer Research · doi:10.21037/tlcr.2017.05.06 · Cited by 95
Reduced Apolipoprotein M and Adverse Outcomes Across the Spectrum of Human Heart Failure
Chirinos, J. A., Zhao, L., Jia, Y., Frej, C., Adamo, L., Mann, D. L., Shewale, S. V., Millar, J. S., Rader, D. J., French, B. C., et al. (2020) · Circulation · doi:10.1161/circulationaha.119.045323 · Cited by 81
Using the Plasma Proteome for Risk Stratifying Patients with Pulmonary Arterial Hypertension
Rhodes, C. J., Wharton, J., Świetlik, E. M., Harbaum, L., Girerd, B., Coghlan, G., Lordan, J., Church, C., Pepke‐Żaba, J., Toshner, M. R., et al. (2022) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202105-1118oc · Cited by 83
Alexaki, A., Hettiarachchi, G. K., Athey, J. C., Katneni, U. K., Simhadri, V., Hamasaki-Katagiri, N., Nanavaty, P., Lin, B., Takeda, K., Freedberg, D., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-51984-2 · Cited by 78
Hillary, R. F., McCartney, D. L., Harris, S. E., Stevenson, A. J., Seeboth, A., Zhang, Q., Liewald, D. C., Evans, K. L., Ritchie, C. W., Tucker-Drob, E. M., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-11177-x · Cited by 78
Davis, M. M., & Brodin, P. (2018) · Annual Review of Immunology · doi:10.1146/annurev-immunol-042617-053206 · Cited by 77
Coronary Artery Disease and Type 2 Diabetes: A Proteomic Study
Ferrannini, G., Manca, M. L., Magnoni, M., Andreotti, F., Andreini, D., Latini, R., Maseri, A., Maggioni, A. P., Ostroff, R. M., Williams, S. A., et al. (2020) · Diabetes Care · doi:10.2337/dc19-1902 · Cited by 90
Self-citationIsolation of Natural DNA Aptamers for Challenging Small-Molecule Targets, Cannabinoids
Yu, H., Luo, Y., Alkhamis, O., Canoura, J., Yu, B., & Xiao, Y. (2021) · Analytical Chemistry · doi:10.1021/acs.analchem.0c04592 · Cited by 81
Shah, A. M., Myhre, P. L., Arthur, V., Dorbala, P., Rasheed, H., Buckley, L. F., Claggett, B. L., Liu, G., Ma, J., Nguyen, N. Q., et al. (2024) · Nature Communications · doi:10.1038/s41467-023-44680-3 · Cited by 100
APOE ε4 carriers share immune-related proteomic changes across neurodegenerative diseases
Shvetcov, A., Johnson, E. C. B., Winchester, L. M., Walker, K. A., Wilkins, H. M., Thompson, T. G., Rothstein, J. D., Krish, V., Imam, F. B., The Global Neurodegeneration Proteomics Consortium (GNPC), et al. (2025) · Nature Medicine · doi:10.1038/s41591-025-03835-z · Cited by 78
“1 assay, which measures approximately 7,000 proteins 74,75 .”
Ramalingam, P., Poulos, M. G., Lazzari, E., Gutkin, M. C., Lopez, D., Kloss, C. C., Crowley, M. J., Katsnelson, L., Freire, A. G., Greenblatt, M. B., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-14478-8 · Cited by 78
Zhu, Z., Song, Y., Li, C., Zou, Y. W., Zhu, L., An, Y., & Yang, C. J. (2014) · Analytical Chemistry · doi:10.1021/ac501423g · Cited by 80
DNA-Catalyzed Amide Hydrolysis
Zhou, C., Avins, J. L., Klauser, P. C., Brandsen, B. M., Lee, Y., & Silverman, S. K. (2016) · Journal of the American Chemical Society · doi:10.1021/jacs.5b12647 · Cited by 96
Genetic Architecture of the Cardiovascular Risk Proteome
Benson, M. D., Yang, Q., Ngo, D., Zhu, Y., Shen, D., Farrell, L. A., Sinha, S., Keyes, M. J., Vasan, R. S., Larson, M. G., et al. (2018) · Circulation · doi:10.1161/circulationaha.117.029536 · Cited by 77
Placenta accreta spectrum: biomarker discovery using plasma proteomics
Shainker, S. A., Silver, R. M., Modest, A. M., Hacker, M. R., Hecht, J. L., Salahuddin, S., Dillon, S. T., Ciampa, E. J., D’Alton, M. E., Otu, H. H., et al. (2020) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2020.03.019 · Cited by 83
Rooney, M. R., Chen, J., Ballantyne, C. M., Hoogeveen, R. C., Tang, O., Grams, M. E., Tin, A., Ndumele, C. E., Zannad, F., Couper, D. J., et al. (2023) · Clinical Chemistry · doi:10.1093/clinchem/hvac186 · Cited by 77
Aptamer-Gated Nanoparticles for Smart Drug Delivery
Özalp, V. C., Eyidoğan, F., & Öktem, H. A. (2011) · Pharmaceuticals · doi:10.3390/ph4081137 · Cited by 83
Key Aspects of Nucleic Acid Library Design for in Vitro Selection
Vorobyeva, M., Davydova, A., Vorobjev, P., Pyshnyi, D. V., & Venyaminova, A. G. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19020470 · Cited by 89
Zhang, J., Shi, J., Liu, W., Zhang, K., Zhao, H., Zhang, H., & Zhang, Z. (2018) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2018.08.056 · Cited by 77
Duffy, D. C. (2023) · Lab on a Chip · doi:10.1039/d2lc00783e · Cited by 88
Applications of aptamer affinity chromatography
Zhao, Q., Wu, M., Le, X. C., & Li, X. (2012) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2012.08.005 · Cited by 78
Shi, L., Westwood, S., Baird, A. L., Winchester, L., Dobricic, V., Kilpert, F., Hong, S., Franke, A., Hye, A., Ashton, N. J., et al. (2019) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2019.06.4951 · Cited by 74
Modified nucleic acid aptamers: development, characterization, and biological applications
Ji, D., Feng, H., Liew, S. W., & Kwok, C. K. (2023) · Trends in biotechnology · doi:10.1016/j.tibtech.2023.05.005 · Cited by 78
Technical Evaluation of Plasma Proteomics Technologies
Beimers, W. F., Overmyer, K. A., Sinitcyn, P., Lancaster, N. M., Quarmby, S. T., & Coon, J. J. (2025) · Journal of Proteome Research · doi:10.1021/acs.jproteome.5c00221 · Cited by 72
Szeto, K., Latulippe, D. R., Ozer, A., Pagano, J. M., White, B. S., Shalloway, D. I., Lis, J. T., & Craighead, H. G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0082667 · Cited by 81
The Effects of α -Lipoic Acid against Testicular Ischemia-Reperfusion Injury in Rats
Özbal, S., Ergür, B. U., Erbil, G., Tekmen, I., Bağrıyanık, A., & Çavdar, Z. (2012) · The Scientific World JOURNAL · doi:10.1100/2012/489248 · Cited by 74
Architecture of high-affinity unnatural-base DNA aptamers toward pharmaceutical applications
Matsunaga, K., Kimoto, M., Hanson, C. A., Sanford, M. E., Young, H. A., & Hirao, I. (2015) · Scientific Reports · doi:10.1038/srep18478 · Cited by 76
Motzer, R. J., Hutson, T. E., Hudes, G. R., Figlin, R. A., Martini, J.-F., English, P. A., Huang, X., Valota, O., & Williams, J. A. (2014) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-014-2539-0 · Cited by 80
Metadata
- Authors
- Gold, L., Ayers, D., Bertino, J., Bock, C., Bock, A., Brody, E. N., Carter, J., Dalby, A. B., Eaton, B. E., Fitzwater, T., Flather, D., Forbes, A., Foreman, T., Fowler, C., Gawande, B., Goss, M., Gunn, M., Gupta, S., Halladay, D., Heil, J., Heilig, J., Hicke, B., Husar, G., Janjic, N., Jarvis, T., Jennings, S., Katilius, E., Keeney, T. R., Kim, N., Koch, T. H., Kraemer, S., Kroiss, L., Le, N., Levine, D., Lindsey, W., Lollo, B., Mayfield, W., Mehan, M., Mehler, R., Nelson, S. K., Nelson, M., Nieuwlandt, D., Nikrad, M., Ochsner, U., Ostroff, R. M., Otis, M., Parker, T., Pietrasiewicz, S., Resnicow, D. I., Rohloff, J., Sanders, G., Sattin, S., Schneider, D., Singer, B., Stanton, M., Sterkel, A., Stewart, A., Stratford, S., Vaught, J. D., Vrkljan, M., Walker, J. J., Watrobka, M., Waugh, S., Weiss, A., Wilcox, S. K., Wolfson, A., Wolk, S. K., Zhang, C., & Zichi, D.
- Affiliations
- University of Colorado Boulder (US)
- SomaLogic (United States) (US)
- Cornell University (US)
- Corresponding author
- Gold, Larry
- Walker, Jeffrey J.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2010-12-07
- Volume
- 5
- Issue
- 12
- Pages
- e15004
- ISSN
- 1756-0357 (ISSN-L)
- 1932-6203
- PMC
- PMC3000457
- OpenAlex
- W2084373725
- Cited by
- 1,754
- References
- 46
- Citations by year
- 2026: 164 · 2025: 190 · 2024: 170 · 2023: 154 · 2022: 184 · 2021: 127 · 2020: 115 · 2019: 105 · 2018: 95 · 2017: 98 · 2016: 78 · 2015: 73 · 2014: 60 · 2013: 56 · 2012: 50
- Type
- posted content
- Language
- en
- Open access
- diamond
- doi.org
- Locations
- Nature Precedings (publishedVersion, cc-by)
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Nature Precedings (submittedVersion)
- Funders
- University of Washington
- National Institutes of Health
- National Cancer Institute
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Advanced biosensing and bioanalysis techniques
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Advanced Biosensing Techniques and Applications
- Physical Sciences › Chemistry › Spectroscopy › Advanced Proteomics Techniques and Applications
- Keywords
- aptamer-based proteomics, biomarker discovery, chemically modified nucleotides, DNA microarrays, plasma protein profiling, chronic kidney disease, multiplexed protein quantification, aptamer selection, disease biomarkers
- MeSH terms
- Aged, Female, Genetic Techniques, Glomerular Filtration Rate, Humans, Kidney Failure, Chronic, Kinetics, Male, Middle Aged, Nucleic Acid Hybridization, Mass Spectrometry, Reproducibility of Results, Biomarkers, Gene Library, Evidence-Based Medicine, Oligonucleotide Array Sequence Analysis, Proteome, Proteomics, Aptamers, Nucleotide
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.